Skip to content
Open access

Dose-dependent effects of fingolimod on behavioral, molecular, and Stereological outcomes in a rat model of intracerebroventricular streptozotocin-induced Alzheimer’s disease-like cognitive dysfunction

Aug 2026 · 3 Biotech · Vol 16 · 0 citations · 96 references
Medicine

TL;DR

Fingolimod exerted dose-dependent, domain-specific effects, with lower doses improving functional outcomes and the intermediate dose providing greater preservation of hippocampal structure, suggesting beneficial effects within the doses examined.

Read PDF

Similar papers

Aug 2026

Hippocampal Klotho Expression Is Associated with the Neuroprotective Effects of Metformin Against ICV-STZ-Induced Cognitive Deficits.

Alzheimer's disease (AD) is characterized by progressive cognitive decline, amyloid-β (Aβ) accumulation, oxidative stress, and neuroinflammation. Increasing evidence links metabolic dysfunction to AD, suggesting that antidiabetic drugs such as metformin may exert neuroprotective effects. This study investigated the eff...

Farzane Shanehbandpour-Tabari, Ravieh Golchoobian, F. Pourabdolhossein · 0 citations
Open access Sep 2026

L-carnitine attenuates Aβ₁-₄₂-induced spatial cognitive deficits and hippocampal dysfunction in a rat model of Alzheimer's disease.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive dysfunction and impaired synaptic plasticity. This study evaluated whether chronic L-carnitine (LC) attenuates amyloid-beta 1-42 (Aβ₁-₄₂)-induced spatial learning and memory deficits following intracerebroventricular (ICV) A...

Hamid Shokati Basir, Masome Rashno, Parsa Gholipour et al. · 0 citations
Aug 2026

Formononetin Attenuates Seizure Severity and Cognitive Deficits in PTZ-Kindled Rats with Associated Changes in Oxidative Stress and P2 X 7/IL-1β/Glutamate Signalling Markers

It is suggested that FMNT attenuates PTZ-kindling-associated seizure severity and cognitive deficits, potentially through antioxidant effects and suppression of P2 X 7/IL-1β/glutamate-associated inflammatory signalling.

Harsh Yadav, B. Thawkar, Nisarg S. Sawant · 0 citations
Open access Sep 2026

To Study the Effect of Nilotinib, a Tyrosine Kinase Inhibitor, on Learning and Memory and Its Comparison with Nitric Oxide Synthase Inhibitor in an Animal Model of Alzheimer’s Disease

Background Alzheimer’s disease (AD) is a gradual neurodegenerative disorder presenting with cognitive and non-cognitive impairment. Currently approved therapies alleviate symptoms but do not modify disease progression and may be associated with adverse effects. Objective This study aimed to compare the effect of niloti...

Anurag Kumar, Nasreen Fatima, Pramod Kumar et al. · 0 citations
Open access Jul 2026

Neuroprotective Effects of Empagliflozin Against Methamphetamine-Induced Withdrawal Syndrome in Mice: Involvement of Bdnf, Tlr4, and JNK Signaling Pathways and Oxidative Stress Biomarkers

Empagliflozin confers robust behavioral, antioxidant, anti-inflammatory, and neuroprotective effects during methamphetamine withdrawal, and this animal study support empagliflozin as a potential treatment for neuropsychiatric dysfunction associated with METH withdrawal.

H. Ghavimi, M. Ebrahimi, Maede Hasanzadeh et al. · 0 citations
Open access Sep 2026

Modulation of spatial learning and memory by cannabinoid–estrogen interaction in an AD-like cognitive impairment: The role of cannabinoid receptors and BDNF protein

Alzheimer’s disease (AD) is an increasingly prevalent neurodegenerative disorder worldwide, with women showing a higher risk of developing the disease. The decline in steroid hormones after menopause may contribute to the increased susceptibility of women to neurodegenerative conditions. In parallel, cannabis-derived c...

M. Mirshekar, Farzaneh Nadi, Hamed Fanaei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.